Written answers
Tuesday, 18 November 2014
Department of Health
Medicinal Products Availability
Andrew Doyle (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
408. To ask the Minister for Health the reason the drug Roflumilast has been removed from the drugs payment scheme; and if he will make a statement on the matter. [44158/14]
Kathleen Lynch (Cork North Central, Labour)
Link to this: Individually | In context | Oireachtas source
The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.
No comments